OPTN In this morning. Currently $5.92 +22% Small cap ($270M) beginning study of its nasal spray for treatment of covid 19 in the sinus cavity, where the virus is thought to begin its passage into the respiratory system. Good finances and share structure. Good anal rating and 'tutes. Two recent upgrades to BUY. PT 19 Piper
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.